• 1
    Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999; 20: 76187.
  • 2
    Burger AM, Leyland-Jones B, Banerjee K, Spyropoulos DD, Seth AK. Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer. Eur J Cancer 2005; 41: 151527.
  • 3
    Rechler MM. Insulin-like growth factor binding proteins. Vitam Horm Rev 1993; 47: 1114.
  • 4
    Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrinol Rev 1995; 16: 334.
  • 5
    Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, Rosenfeld RG. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7: Recombinant human mac25 protein specifically binds IGF-I and -II. J Biol Chem 1996; 271: 30 3225.
  • 6
    Akaogi K, Sato J, Okabe Y, Sakamoto Y, Yasumitsu H, Miyazaki K. Synergistic growth stimulation of mouse fibroblasts by tumor-derived adhesion factor with insulin-like growth factors and insulin. Cell Growth Differ 1996; 7: 16717.
  • 7
    Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S, Nawata H. Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem J 1994; 303: 5918.
  • 8
    Murphy M, Pykett MJ, Harnish P, Zang KD, George DL. Identification and characterization of genes differently expressed in meningiomas. Cell Growth Differ 1993; 4: 71522.
  • 9
    Akaogi K, Okabe Y, Funahashi K et al . Cell adhesion activity of a 30-kDa major secreted protein from human bladder carcinoma cells. Biochem Biophys Res Commun 1994; 198: 104653.
  • 10
    Akaogi K, Okabe Y, Sato J et al . Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc Natl Acad Sci USA 1996; 93: 83849.
  • 11
    Sato J, Hasegawa S, Akaogi K et al . Identification of cell-binding site of angiomodulin (AGM/TAF/Mac25) that interacts with heparan sulfates on cell surface. J Cell Biochem 1999; 75: 18795.
  • 12
    Kishibe J, Yamada S, Okada Y et al . Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells. J Biol Chem 2000; 275: 15 3219.
  • 13
    Ahmed S, Yamamoto K, Sato Y et al . Proteolytic processing of IGFBP-related protein-1 (TAF/angiomodulin/mac25) modulates its biological activity. Biochem Biophys Res Commun 2003; 310: 61218.
  • 14
    Adachi Y, Itoh F, Yamamoto H et al . Expression of angiomodulin (tumor-derived adhesion factor/mac25) in invading tumor cells correlates with poor prognosis in human colorectal cancer. Int J Cancer 2001; 95: 21622.
  • 15
    Degeorges A, Wang F, Frierson HF Jr, Seth A, Sikes RA. Distribution of IGFBP-rP1 in normal human tissues. J Histochem Cytochem 2000; 48: 74754.
  • 16
    Swisshelm K, Ryan K, Tsuchiya K, Sager R. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc Natl Acad Sci USA 1995; 92: 44726.
  • 17
    Komatsu S, Okazaki Y, Tateno M et al . Methylation and downregulated expression of mac25/insulin-like growth factor binding protein-7 is associated with liver tumorigenesis in SV40T/t antigen transgenic mice, screened by restriction landmark genomic scanning for methylation (RLGS-M). Biochem Biophys Res Commun 2000; 267: 10917.
  • 18
    Wilson HM, Birnbaum RS, Poot M, Quinn LS, Swisshelm K. Insulin-like growth factor binding protein-related protein 1 inhibits proliferation of MCF-7 breast cancer cells via a senescence-like mechanism. Cell Growth Differ 2002; 13: 20513.
  • 19
    Burger AM, Zhang X, Li H et al . Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene 1998; 16: 245967.
  • 20
    Hwa V, Tomasini-Sprenger C, Bermejo AL, Rosenfeld RG, Plymate SR. Characterization of insulin-like growth factor-binding protein-related protein-1 in prostate cells. J Clin Endocrinol Metab 1998; 83: 435562.
  • 21
    Sprenger CC, Damon SE, Hwa V, Rosenfeld RG, Plymate SR. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer. Cancer Res 1999; 59: 23705.
  • 22
    Sprenger CC, Vail ME, Evans K, Simurdak J, Plymate SR. Over-expression of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis. Oncogene 2002; 21: 1407.
  • 23
    Kato MV. A secreted tumour-suppressor, mac25, with activin-binding activity. Mol Med 2000; 6: 12635.
  • 24
    Kariya Y, Ishida K, Tsubota Y et al . Efficient expression system of human recombinant laminin-5. J Biochem 2004; 132: 60712.
  • 25
    Hirosaki T, Mizushima H, Tsubota Y, Moriyama K, Miyazaki K. Structural requirement of carboxyl-terminal globular domains of laminin alpha 3 chain for promotion of rapid cell adhesion and migration by laminin-5. J Biol Chem 2000; 275: 22 495502.
  • 26
    Ahmed S, Jin X, Yagi M et al . Identification of membrane-bound serine proteinase matriptase as a processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25). FEBS J 2006; 273: 61527.
  • 27
    Mutaguchi K, Yasumoto H, Mita K et al . Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer. Cancer Res 2003; 63: 771723.
  • 28
    Chen Y, Pacyna-Genqelbach M, Ye F et al . Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) has potential tumour-suppressive activity in human lung cancer. J Pathol 2007; 211: 4318.
  • 29
    Guo W, Giancotti FG. Integrin signaling during tumor progression. Nat Rev Mol Cell Biol 2004; 5: 81626.
  • 30
    Yamada KM, Even-Ram S. Integrin regulation of growth factor receptors. Nat Cell Biol 2002; 4: E756.
  • 31
    Umeda F, Ono Y, Sekiguchi N et al . Increased mRNA expression of a novel prostacyclin-stimulating factor in human colon cancer. J Gastroenterol 1998; 33: 21317.
  • 32
    Usui T, Murai T, Tanaka T et al . Characterization of mac25/angiomodulin expression by high endothelial venule cells in lymphoid tissues and its identification as an inducible marker for activated endothelial cells. Int Immunol 2002; 14: 127382.
  • 33
    Nagakubo D, Murai T, Tanaka T et al . A high endothelial venule secretory protein, mac25/angiomodulin, interacts with multiple high endothelial venule-associated molecules including chemokines. J Immunol 2003; 171: 55361.
  • 34
    Salahifar H, Firth SM, Baxter RC, Martin JL. Characterization of an amino-terminal fragment of insulin-like growth factor binding protein-3 and its effects in MCF-7 breast cancer cells. Growth Horm IGF Res 2000; 10: 36777.
  • 35
    Leal SM, Huang SS, Huang JS. Interactions of high affinity insulin-like growth factor-binding proteins with the type V transforming growth factor-β receptor in mink lung epithelial cells. J Biol Chem 1999; 274: 671117.
  • 36
    Schedlich LJ, Young TF, Firth SM, Baxter RC. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 1998; 273: 18 34752.
  • 37
    Diehl D, Hoeflich A, Wolf E, Lahm H. Insulin-like growth factor (IGF)-binding protein-4 inhibits colony formation of colorectal cancer cells by IGF-independent mechanisms. Cancer Res 2004; 64: 16003.
  • 38
    Yamanaka Y, Wilson EM, Rosenfeld RG, Oh Y. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem 1997; 272: 30 72934.